# Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)

> **NCT04156841** · — · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 21000 (estimated)

## Conditions studied

- Breast Cancer
- Sentinel Lymph Node

## Interventions

- **DIAGNOSTIC_TEST:** mapping agent
- **PROCEDURE:** neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT04156841
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 21000 (ESTIMATED)
- **Last updated:** 2019-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04156841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04156841, "Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04156841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*